Response of human epidermal growth factor receptor 2-positive colorectal cancer to lapatinib monotherapy: A case report

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) amplification is a molecular driver for a subset of colorectal cancers (CRCs) and one of the major causes of anti-epidermal growth factor receptor (EGFR) treatment failure. Compared to dual anti-HER2 treatments, which have been shown to be...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Ji-Lin, Liu, Jian-Hua, Wang, Qing, Cong, Yu-Wei, Chen, Yao-Xu, Huang, Ke-Fei, Huang, Meng-Li, Huang, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509996/
https://www.ncbi.nlm.nih.gov/pubmed/33005299
http://dx.doi.org/10.4251/wjgo.v12.i9.1065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7509996/
https://www.ncbi.nlm.nih.gov/pubmed/33005299
http://dx.doi.org/10.4251/wjgo.v12.i9.1065

Ejemplares similares